Live feed/
Filings
/
SCHEDULE
/
0001104659-25-014908
Stake: 11.00%
Shares: 6,132,802
CUSIP: 03763A207
Class: Common Stock, $0.001 par value per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE)
Conviction Score: 24/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -20.4%
- Passive Schedule 13G filer baseline
- High conviction ownership stake (11.0%)
- 12 NPORT-P mutual funds holding CUSIP
- Elevated short days-to-cover (8.8 DTC)
Item 4 — Purpose of Transaction
Item 4 is hereby amended to add the following: On January 15, 2025, the Reporting Person declared a dividend on the Reporting Person's common stock, payable by the pro rata distribution, for no consideration, of an aggregate of 699,896 shares of the Issuer's Common Stock to the Reporting Person's stockholders, including 17,839 shares in the aggregate held for the benefit of disqualified shareholders of the Reporting Person. The shares of Common Stock were distributed on February 15, 2025. The Reporting Person acquired the Common Stock reported in this Statement for investment purposes. The Reporting Person may in the future acquire additional shares of Common Stock or dispose of some or all of the shares of Common Stock beneficially owned by it in open-market transactions or privately negotiated transactions, on such terms and at such times as it may deem advisable. The Reporting Person may engage in hedging or similar transactions with respect to the shares of Common Stock, on such terms and at such times as the Reporting Person may deem advisable, subject to applicable law. The Reporting Person does not have any present plan or proposal that would result in any of the actions described in paragraphs (a) through (j) of Item 4 of Schedule 13D, except as set forth herein or as may be proposed by officers or directors of the Reporting Person in their capacity as an officer and/or director of the Issuer or by the Board of Directors of the Issuer with their participation. The Reporting Person reserves the right in the future to formulate any such plans or proposals, and to take any actions with respect to its investments in the Issuer, including any or all of the actions described in paragraphs (a) through (j) of Item 4 of Schedule 13D
Cross-References
Insider Activity (last 365d)
2 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
5 filings by this filer
4 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 8.85
3,010,140 shares short · -2.5% vs prior
Post-Filing Returns · since 2025-02-15 on ASTH
Anchor price 38.90 on closest trading day on/after 2025-02-15. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
| 2026-10-06 |
Lam Thomas S. |
director |
F |
2,624 |
$37.00 |
$97K |
| 2026-10-02 |
Basho Chandan |
officer |
F |
2,092 |
$35.88 |
$75K |
Other 13D/G Filings on Astrana Health, Inc.
| Filed | Form | Filer | Stake | Shares | |
| 2026-07-31 |
SCHEDULE 13G |
VANGUARD PORTFOLIO MANAGEMENT LLC |
— |
— |
view → |
| 2025-01-22 |
SCHEDULE |
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp |
12.20% |
6,832,698 |
view → |
| 2021-07-08 |
SC |
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp |
— |
— |
view → |
| 2020-02-25 |
SC |
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp |
— |
— |
view → |
| 2020-02-24 |
SC |
Sakhrani Lakhi |
— |
— |
view → |
| 2020-02-24 |
SC |
Sim Kenneth T. |
— |
— |
view → |
| 2020-02-24 |
SC |
Lam Thomas S. |
— |
— |
view → |
| 2019-09-17 |
SC |
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp |
— |
— |
view → |
Other Filings by ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp
| Filed | Form | Issuer | Stake | Shares | |
| 2025-01-22 |
SCHEDULE |
Astrana Health, Inc. ASTH |
12.20% |
6,832,698 |
view → |
| 2021-07-08 |
SC |
Apollo Medical Holdings, Inc. ASTH |
— |
— |
view → |
| 2020-02-25 |
SC |
Apollo Medical Holdings, Inc. ASTH |
— |
— |
view → |
| 2019-09-17 |
SC |
Apollo Medical Holdings, Inc. ASTH |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →